Tarsus Pharmaceuticals Inc. (TARS)
NASDAQ · Healthcare
Tarsus Pharmaceuticals Inc. annual/quarterly long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Tarsus Pharmaceuticals Inc. long term debt for the quarter ending December 31, 2025 were 72.4M, a 0.83% increase year-over-year.
- Tarsus Pharmaceuticals Inc. long term debt for 2025 were 72.4M, a 0.83% increase from 2024.
- Tarsus Pharmaceuticals Inc. long term debt for 2024 were 71.8M, a 140.94% increase from 2023.
- Tarsus Pharmaceuticals Inc. long term debt for 2023 were 29.8M, a 53.44% increase from 2022.
- Tarsus Pharmaceuticals Inc. long term debt for 2022 were 19.4M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Tarsus Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $72 |
| 2024 | $72 |
| 2023 | $30 |
| 2022 | $19 |
| Tarsus Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $72 |
| 2024-12-31 | $72 |
| 2023-12-31 | $30 |
| 2022-12-31 | $19 |
Tarsus Pharmaceuticals Inc. Long Term Debt — FAQ
Tarsus Pharmaceuticals Inc. (TARS) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TARS's long term debt history?
The chart and table above show Tarsus Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.